ATCH vs MGLD
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
ATCH exhibits severe fundamental weakness, highlighted by a Piotroski F-Score of 2/9, indicating poor financial health and deteriorating operational efficiency. While the company shows explosive top-line revenue growth (84.10% YoY) and strong gross margins (83.48%), these are offset by negative operating margins (-16.76%) and a bearish technical trend. The lack of a Graham Number or Intrinsic Value baseline, combined with a micro-cap valuation and low insider sentiment, suggests a high-risk speculative profile. Despite a 'strong_buy' rating from a single analyst, the deterministic health metrics signal significant instability.
The Marygold Companies exhibits severe financial weakness, highlighted by a critical Piotroski F-Score of 1/9, indicating a significant deterioration in fundamental health. While the company maintains a strong liquidity position with a current ratio of 3.90 and very low debt, it is plagued by negative profit margins (-11.85%) and shrinking year-over-year revenue growth (-4.50%). The combination of negative ROE, a bearish technical trend, and a high Price-to-Book ratio (2.08) for a loss-making entity suggests the stock is fundamentally overvalued. Despite a slight recovery in 1-year price performance, the long-term 5-year trend remains deeply negative (-67.5%).
Compare Another Pair
Related Comparisons
ATCH vs MGLD: Head-to-Head Comparison
This page compares AtlasClear Holdings, Inc. (ATCH) and The Marygold Companies, Inc. (MGLD) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.